Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Akums Drugs and Pharmaceuticals Limited ( (IN:AKUMS) ) has issued an announcement.
Akums Drugs and Pharmaceuticals Limited has announced the closure of its trading window for designated persons and their immediate relatives from 1 January 2026 until 48 hours after the declaration of its unaudited financial results for the quarter ending 31 December 2025, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015 and its internal code of conduct on insider trading. The company added that the date of the board meeting to consider and approve these quarterly unaudited results will be communicated separately, underscoring its adherence to regulatory norms governing disclosure and trading in its securities.
More about Akums Drugs and Pharmaceuticals Limited
Akums Drugs and Pharmaceuticals Limited operates in the pharmaceuticals industry, focusing on the manufacture and trading of drug and healthcare formulations, with its securities listed on the National Stock Exchange of India and BSE.
Average Trading Volume: 12,941
Technical Sentiment Signal: Sell
Current Market Cap: 70.28B INR
For an in-depth examination of AKUMS stock, go to TipRanks’ Overview page.